Our own Josh Russell, VP of Technical Sales, sat down with INTERPHEX Global TV to dive into AST’s latest drug manufacturing innovations showcased at INTERPHEX 2025, and discussed current industry trends and the importance of turnkey solutions for meeting evolving product demands
AST kicked off our 60th anniversary as a company by bringing the latest in comprehensive, forward-looking aseptic processing product and service advancements to the Javitz Center, NYC. Our exhibit at INTERPHEX featured our new fully automatic GENiSYS® C, a fourth-generation fill-finish system designed to meet and exceed regulations, including the latest Annex 1. The system showcased at INTERPHEX will be placed with Ascend Advanced Therapies, a specialist adeno-associated virus (AAV) development partner, at their state-of-the-art manufacturing facility in Alachua, Florida.
Alongside the advanced fill-finish system, AST unveiled two new turnkey advancements, offering demonstrations of our new glove testing system, Shield™GIT, and new digital twin solution. Josh discusses all this and more in the exclusive interview below:
